<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17238/PmJ1609-1175.2017.4.40-44</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-182</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Молекулярные подтипы остеоартрита</article-title><trans-title-group xml:lang="en"><trans-title>Molecular subtypes of osteoarthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кабалык</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kabalyk</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">maxi_maxim@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гнеденков</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gnedenkov</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коваленко</surname><given-names>Т. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovalenko</surname><given-names>T. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синенко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinenko</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Молдованова</surname><given-names>Л. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Moldovanova</surname><given-names>L. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Тихоокеанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pacific State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт химии ДВО РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Chemistry of the FEB RAS</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2017</year></pub-date><volume>0</volume><issue>4</issue><fpage>40</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кабалык М.А., Гнеденков С.В., Коваленко Т.С., Синенко А.А., Молдованова Л.М., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Кабалык М.А., Гнеденков С.В., Коваленко Т.С., Синенко А.А., Молдованова Л.М.</copyright-holder><copyright-holder xml:lang="en">Kabalyk M.A., Gnedenkov S.V., Kovalenko T.S., Sinenko A.A., Moldovanova L.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/182">https://www.tmj-vgmu.ru/jour/article/view/182</self-uri><abstract><p>Обследовано 65 больных остеоартритом (ОА) коленных суставов: 8 мужчин и 57 женщин, средний возраст - 66,7 года, длительность заболевания от 1 до 18 лет. На основании молекулярного анализа выделены воспалительный, оксидативный и смешанный молекулярно-биологические подтипы заболевания. Среди пациентов с ОА обнаружена фенотипическая дисперсия с равным преобладанием оксидативного и смешанного вариантов. Воспалительный эндотип встречается лишь в 13,8% случаев. У больных с воспалительным молекулярным эндотипом не наблюдалось «поздних» стадий гонартроза, в то время как III-IV стадии выявлены у 42,8% пациентов со смешанным подтипом. Воспалительный подтип характеризовался высоким уровнем пролиферативной клеточной активности, низким апоптозом и синтетической активностью коллагенового матрикса. При окислительном подтипе наблюдались активные процессы апоптоза в условиях дисфункции эндотелия сосудов и низкой клеточной пролиферации. Смешанный молекулярный подтип характеризуется высоким уровнем апоптоза и синтетической активности пролилгидорлазы в отношении коллагенового матрикса, которые реализовались в условиях высокой ангиопролиферации и дисфункции эндотелия.</p></abstract><trans-abstract xml:lang="en"><p>Objective. The study objective is to evaluate the clinical and pathogenetic relationships of the inflammatory, oxidative and mixed molecular subtypes / endotypes of osteoarthritis. Methods. 65 patients with osteoarthritis of knee joints were examined: 8 men and 57 women, average age - 66.7 years, duration of the disease from 1 to 18 years. For the purpose of molecular phenotyping, the concentrations of interleukin-1 ß and oxidative-induced growth inhibitor-1 were determined in the blood serum and phenotypes of the osteoarthritis: inflammatory, oxidative and mixed were isolated. Results. Inflammatory endotypes occurred in 9, oxidative - in 28 and mixed - in 28 cases. The pain level, measured from the visual analogue scale, was the lowest in individuals with an inflammatory molecular subtype of the osteoarthritis. The overall score for the WOMAC questionnaire was significantly higher in patients with a mixed endotypes of the disease. The concentration of cartilage-associated protein was significantly lower in patients with inflammatory and oxidative molecular subtypes of osteoarthritis. The level of the Fas-ligand was significantly lower in the inflammatory subtype, and the level of endothelin-1 was lower in the oxidative subtype of the disease. The growth factor/differentiation-5 concentration was significantly higher in the group with the inflammatory osteoarthritis phenotype. Conclusions. The osteoarthritis is a heterogeneous disease; the variety of its manifestations depends on the molecular-transcriptom mechanisms and ways of responding to stress. Endotyping patients with osteoarthritis on molecular basis is justified from the clinical and pathogenetic point of view. Thus, the data obtained by us on the clinical and pathogenetic features of various molecular phenotypes of the osteoarthritis can form the basis of a personified approach in this disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>остеоартрит</kwd><kwd>фенотип</kwd><kwd>воспаление</kwd><kwd>оксидативный стресс</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Алексеева Л.И., Цветкова Е.С. Остеоартроз: из прошлого в будущее // Научно-практическая ревматология. 2009. Прил. 2. С. 31-37</mixed-citation><mixed-citation xml:lang="en">Алексеева Л.И., Цветкова Е.С. Остеоартроз: из прошлого в будущее // Научно-практическая ревматология. 2009. Прил. 2. С. 31-37</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Зайцева Е.М., Алексеева Л.И. Причины боли при остеоартрозе и факторы прогрессирования заболевания // Научно-практическая ревматология. 2011. № 1. С. 50-57</mixed-citation><mixed-citation xml:lang="en">Зайцева Е.М., Алексеева Л.И. Причины боли при остеоартрозе и факторы прогрессирования заболевания // Научно-практическая ревматология. 2011. № 1. С. 50-57</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Мустафин РН., Хуснутдинова Э.К. Аваскулярный некроз головки бедренной кости // Тихоокеанский медицинский журнал. 2017. № 1. С. 27-35</mixed-citation><mixed-citation xml:lang="en">Мустафин РН., Хуснутдинова Э.К. Аваскулярный некроз головки бедренной кости // Тихоокеанский медицинский журнал. 2017. № 1. С. 27-35</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmad R., Sylvester J., Ahmad M., Zafarullah M. Involvement of H-Ras and reactive oxygen species in proinflammatory cytokine-induced matrix metalloproteinase-13 expression in human articular chondrocytes // Arch. Biochem. Biophys. 2011. Vol. 507, No. 2. P. 350-355.</mixed-citation><mixed-citation xml:lang="en">Ahmad R., Sylvester J., Ahmad M., Zafarullah M. Involvement of H-Ras and reactive oxygen species in proinflammatory cytokine-induced matrix metalloproteinase-13 expression in human articular chondrocytes // Arch. Biochem. Biophys. 2011. Vol. 507, No. 2. P. 350-355.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dalen S.C., Blom A.B., Slöetjes A.W. [et al.]. Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis // Osteoarthritis Cartilage. 2017. Vol. 25, No. 3. P. 385-396.</mixed-citation><mixed-citation xml:lang="en">Dalen S.C., Blom A.B., Slöetjes A.W. [et al.]. Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis // Osteoarthritis Cartilage. 2017. Vol. 25, No. 3. P. 385-396.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Deveza L.A., Melo L., Yamato T.P. [et al.]. Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review // Osteoarthritis Cartilage. 2017. Vol. 25, No. 9. P 452-456.</mixed-citation><mixed-citation xml:lang="en">Deveza L.A., Melo L., Yamato T.P. [et al.]. Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review // Osteoarthritis Cartilage. 2017. Vol. 25, No. 9. P 452-456.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kraus V.B., Blanco F.J., Englund M. [et al.]. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use // Osteoarthritis Cartilage. 2015. Vol. 23, No. 8. P. 1233-1241.</mixed-citation><mixed-citation xml:lang="en">Kraus V.B., Blanco F.J., Englund M. [et al.]. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use // Osteoarthritis Cartilage. 2015. Vol. 23, No. 8. P. 1233-1241.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Loeser R.F. The role of aging in the development of osteoarthritis // Trans. Am. Clin. Climatol. Assoc. 2017. No. 128. P. 44-54.</mixed-citation><mixed-citation xml:lang="en">Loeser R.F. The role of aging in the development of osteoarthritis // Trans. Am. Clin. Climatol. Assoc. 2017. No. 128. P. 44-54.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Loeser R.F., Gandhi U., Long D.L. [et al.]. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1 // Arthritis Rheumatol. 2014. Vol. 66, No. 8. P 2201-2209.</mixed-citation><mixed-citation xml:lang="en">Loeser R.F., Gandhi U., Long D.L. [et al.]. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1 // Arthritis Rheumatol. 2014. Vol. 66, No. 8. P 2201-2209.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mobasheri A., Bay-Jensen A.C., van Spil W.E. [et al.]. Osteoarthritis Year in Review 2016: biomarkers (biochemical markers) // Osteoarthritis Cartilage. 2017. Vol. 25, No. 2. P. 199-208.</mixed-citation><mixed-citation xml:lang="en">Mobasheri A., Bay-Jensen A.C., van Spil W.E. [et al.]. Osteoarthritis Year in Review 2016: biomarkers (biochemical markers) // Osteoarthritis Cartilage. 2017. Vol. 25, No. 2. P. 199-208.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Münzel T., Camici G.G., Maack C. [et al.]. Impact of oxidative stress on the heart and vasculature: Part 2 of a 3-part series // J. Am. Coll. Cardiol. 2017. Vol. 70, No. 2. P. 212-229.</mixed-citation><mixed-citation xml:lang="en">Münzel T., Camici G.G., Maack C. [et al.]. Impact of oxidative stress on the heart and vasculature: Part 2 of a 3-part series // J. Am. Coll. Cardiol. 2017. Vol. 70, No. 2. P. 212-229.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pan T., Chen R., Wu D. [et al.]. Alpha-Mangostin suppresses interleukin-1ß-induced apoptosis in rat chondrocytes by inhibiting the NF-kB signaling pathway and delays the progression of osteoarthritis in a rat model // Int. Immunopharmacol. 2017. No. 52. P. 156-162.</mixed-citation><mixed-citation xml:lang="en">Pan T., Chen R., Wu D. [et al.]. Alpha-Mangostin suppresses interleukin-1ß-induced apoptosis in rat chondrocytes by inhibiting the NF-kB signaling pathway and delays the progression of osteoarthritis in a rat model // Int. Immunopharmacol. 2017. No. 52. P. 156-162.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Steinberg J., Ritchie G.R.S., Roumeliotis T.I. [et al.]. Integrative epigenomics, transcriptomics and proteomics of patient chondrocytes reveal genes and pathways involved in osteoarthritis // Sci. Rep. 2017. Vol. 7, No. 1. P. 8935.</mixed-citation><mixed-citation xml:lang="en">Steinberg J., Ritchie G.R.S., Roumeliotis T.I. [et al.]. Integrative epigenomics, transcriptomics and proteomics of patient chondrocytes reveal genes and pathways involved in osteoarthritis // Sci. Rep. 2017. Vol. 7, No. 1. P. 8935.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vila S. Inflammation in osteoarthritis // P R. Health Sci. J. 2017. Vol. 36, No. 3. P. 123-129.</mixed-citation><mixed-citation xml:lang="en">Vila S. Inflammation in osteoarthritis // P R. Health Sci. J. 2017. Vol. 36, No. 3. P. 123-129.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yin W., Park J.I., Loeser R.F. Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways // J. Biol. Chem. 2009. Vol. 284, No. 46. P. 31972-31981.</mixed-citation><mixed-citation xml:lang="en">Yin W., Park J.I., Loeser R.F. Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways // J. Biol. Chem. 2009. Vol. 284, No. 46. P. 31972-31981.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">osteoarthritis, phenotype, inflammation, oxidative stress</mixed-citation><mixed-citation xml:lang="en">osteoarthritis, phenotype, inflammation, oxidative stress</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
